Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
CANF

Can-Fite BioPharma

07:58
08/11/17
08/11
07:58
08/11/17
07:58
Initiation
Can-Fite BioPharma initiated at Maxim »

Can-Fite BioPharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CANF

Can-Fite BioPharma

$1.61

0.02 (1.26%)

07:13
08/09/17
08/09
07:13
08/09/17
07:13
Hot Stocks
Can-Fite BioPharma completes patient enrollment for Phase II Namodenoson study »

Can-Fite BioPharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CANF

Can-Fite BioPharma

$1.72

0.11 (6.83%)

07:06
08/07/17
08/07
07:06
08/07/17
07:06
Hot Stocks
Can-Fite BioPharma completes human cardiodynamic safety trial for Piclidenoson »

Can-Fite BioPharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
CANF

Can-Fite BioPharma

$1.80

0.01 (0.56%)

07:01
07/17/17
07/17
07:01
07/17/17
07:01
Hot Stocks
Can-Fite BioPharma says Phase II NAFLD/NASH trial to commence enrollment »

Can-Fite BioPharma said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CANF

Can-Fite BioPharma

$1.80

-0.02 (-1.10%)

07:08
06/08/17
06/08
07:08
06/08/17
07:08
Hot Stocks
Can-Fite concludes clinical investigator meeting for Phase III arthritis trial »

Can-Fite BioPharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CANF

Can-Fite BioPharma

$1.84

-0.03 (-1.60%)

07:26
06/05/17
06/05
07:26
06/05/17
07:26
Hot Stocks
Can-Fite BioPharma establishes Clinical Advisory Board for NAFLD/NASH »

Can-Fite BioPharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
CANF

Can-Fite BioPharma

$1.84

0.07 (3.95%)

07:03
05/16/17
05/16
07:03
05/16/17
07:03
Hot Stocks
Can-Fite BioPharma files application in Canada for Piclidenoson »

Can-Fite BioPharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CANF

Can-Fite BioPharma

$1.83

-0.02 (-1.08%)

07:33
05/03/17
05/03
07:33
05/03/17
07:33
Hot Stocks
Can-Fite BioPharma's Namodenoson enters Phase II trial for NAFLD/NASH »

Can-Fite BioPharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CANF

Can-Fite BioPharma

$1.82

0.01 (0.55%)

07:07
04/25/17
04/25
07:07
04/25/17
07:07
Hot Stocks
Can-Fite BioPharma announces IRB approved Phase III ACRobat trial protocol »

Can-Fite BioPharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CANF

Can-Fite BioPharma

$1.96

0.0024 (0.12%)

07:11
02/28/17
02/28
07:11
02/28/17
07:11
Hot Stocks
Can-Fite BioPharma: Data show Namodenoson prevents liver fibrosis progression »

Can-Fite BioPharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.